Stock Movers Closing Bell: HIMS Surges, Uber & DoorDash Sinks, Paramount Drops
Mar 9, 2026
Markets spotlight dramatic movers: Hims & Hers rockets after a Novo deal. Biotech chatter follows an FDA leadership shakeup. Live Nation climbs on a DOJ settlement for ticket resales. Airlines and semiconductors shift amid S&P reshuffles and fuel worries. Ride-share and delivery stocks slip as oil rises. Paramount Skydance tumbles on takeover and rating headlines.
AI Snips
Chapters
Transcript
Episode notes
Hims Soars After Novo Distribution Deal
- Hims & Hers stock surged after Novo Nordisk agreed to sell its weight-loss injectables and an oral Wegovy via Hims' online pharmacy.
- The deal sent HIMS up ~38–41% intraday and lifted Novo Nordisk shares about 1.9% amid broader S&P 500 weakness.
FDA Turnover Fuels Small Biotech Rally
- FDA leadership change is shifting sentiment for small biotechs working on vaccines, gene therapies, and biologics.
- Capricor gained ~10% and RegenX Bio jumped ~20% on hopes for a more supportive regulatory environment.
Live Nation Rallies After DOJ Settlement
- Live Nation shares rose after the Justice Department settlement forces Ticketmaster to open parts of its ticketing to third-party sellers.
- The agreement may ease antitrust overhang and helped Live Nation climb about 6.2%.